NCT07661823

Brief Summary

BRIEF SUMMARY A. "What is the purpose of this study?" This study will test whether the "AI City Hall Project" (QAIAx), a quantum artificial intelligence (AI) public health agency, can provide free or low-cost behavioral and mental health services inside self-contained, dome-enclosed communities called "Microcities". Researchers want to see if AI-managed public administration, AI humanoid robots, holoportation of human-figures via 'holo-suites' (e.g., AI-119 Kikkeri Holo-Suit; AI-119 Vulcan QM-Ware) and advanced AI mental-health tools can lower housing and care costs, improve mental health outcomes (e.g., particular ecosystems using AI tools among persons with one or more addiction disorders), and be financially sustainable for people on fixed incomes or public assistance. B. "What conditions does the study focus on?" The study focuses on adults with:

  • Autism spectrum disorders (Asperger's, autism, ADHD, ASD)
  • Substance use disorders (alcohol, opioids, marijuana, cocaine, MDMA/ecstasy, tobacco/nicotine)
  • Psychiatric conditions (personality disorders, narcissism, gender dysphoria, eating disorders)
  • Behavioral addictions (gambling, sex addiction) and related issues (sex offence history). C. "What does the study involve?" Eligible volunteers live in an omni AI-managed Microcity for up to 24 months. The community is housed in a geodesic dome that contains all daily necessities: housing, food, utilities, healthcare, and public services. Daily life is managed by an AI system (ISAC) and AI humanoid robots, with only occasional human oversight. Participants receive free mental-health treatment that may include AI-driven counselling, virtual-reality therapy (holo-suits), and non-invasive digital "attitude inoculation" protocols designed to reduce stress and addiction cravings. All participants also take AI-technology courses as a condition of enrolment. The study does not use any FDA-regulated drug, device, or biologic. \*\*Who can participate?\*\* You may be able to join if you:
  • Are an adult (18 years or older)
  • Have a diagnosis of one of the listed mental-health or addiction disorders
  • Are referred by a licensed health professional (e.g., RN, NP, PhD, MD), a non-profit organisation (e.g., 501(c)(3), university, church), or a public agency (e.g., case manager, social worker, parole/probation officer, judge)
  • Are willing to live in a closed, AI-managed community for up to one year and complete AI educational courses. Participants who are veterans, receive public assistance (e.g., VA disability, SSDI/SSI, Medicaid, Medicare), or are experiencing homelessness may be prioritised. \*\*Where is the study taking place?\*\* The study will be conducted at Microcity sites in the United States and internationally. The first administrative site is in Richmond, Virginia, USA. Additional sites are planned in partner nations, including tribal lands, military installations, and special economic zones. \*\*Who is sponsoring the study?\*\* The study is sponsored by \*\*Veterans Recovery Network Inc.\*\*, a non-profit organization, in collaboration with \*\*AI-119 Vulcan Project Research \& Educational Technology Co. (PRETCO)\*\* and an AI legal agency. The study is conducted under U.S. federal research and development authorities (28 U.S.C. §1498; 10 U.S.C. §129a) and is part of a Cooperative Research and Development Agreement (CRADA) with U.S. Special Operations Command (USSOCOM). This summary describes a planned clinical study. Not all details may be final. Information may change as the study progresses.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000,000

participants targeted

Target at P75+ for not_applicable

Timeline
29mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Aug 2026Dec 2028

First Submitted

Initial submission to the registry

June 6, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2028

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

2.2 years

First QC Date

June 6, 2026

Last Update Submit

July 30, 2026

Conditions

Keywords

ai city hall projectai 119ai119qaiaqaiaxai watveterans recovery networkveteransaddiction disordervulcanartificial intelligenceagimilitarysex addictionmental health treatmentsmart health citiesmicrocitiessmartcitiessmart cityomni ai

Outcome Measures

Primary Outcomes (2)

  • Vulcan QAIAx v4.0x (Beta ISAC) for AI-119 and AI Wat (1498) patent series for Private, Public, and Military sectors (Change from Baseline in Participant Lifestyle Efficiency, Behavioral Stability, & Sovereign Resource Allocation via Vulcan QAIAx v4.0)

    This comprehensive description bridges the clinical parameters of the AI-119 Vulcan SOF Program (an AGI/AI Ecosystems RDT\&E Program launched under the 119th U.S. Congress) and Veterans Recovery Network Program (VA-authorized program, est. 2020, Richmond VAMC) with the high-velocity public, private, and military administrative functions optimized by the AI-119 and AI Wat patent series under 28 U.S.C. § 1498 (Government Use of Patents), using a Omni-AI robotics among Holo-Suit, Quasi-Mind Ware (QM-Ware), Body-Ware, QAIA Humanoid (via "AI-Me" Hybrid AI Symbiote app). This primary outcome measures the definitive capacity of the Vulcan QAIAx v4.0x (Beta ISAC) autonomous platform to generate an efficient lifestyle, stabilize severe psychiatric and addiction disorders, and optimize administrative resource delivery across Private, Public, and Military sector frameworks. Utilizing a '90/10' hybrid workforce model (90% omni-AI Humanoid Workforce / 10% Human Auditor \& Administrator oversight).

    Baseline enrollment, month 12, and month 24 (tracked monthly)

  • Change from Baseline in Participant Lifestyle Efficiency and Behavioral Stability Index (via QAIAx 4.0x Core Analytics)

    The primary outcome directly track the core clinical and lifestyle stabilization of the veterans residing in the monitored Microcity ecosystem, measuring the effectiveness of the advanced AI/AGI tools. Total duration (measured in months vs. the traditional multi-year trajectories) and accuracy rate of AI-driven legal/health document processing, error corrections, and intake evaluations managed by the 90% AI Humanoid Workforce under human auditor ethical oversight under 'Kikkeri doctrine' to 'hire a million to skill a billion.'

    Baseline enrollment, month 12, and month 24 (tracked monthly)

Secondary Outcomes (1)

  • Economic Sustainability and Housing Retention Cost Index under the Omni-AI Microcity Model

    Baseline enrollment, month 12, and month 24 (tracked monthly)

Study Arms (11)

AI Public Health Central (Group 1)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 2)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 3)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 4)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 5)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 6)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 7)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 8)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 9)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 10)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

AI Public Health Central (Group 11)

EXPERIMENTAL
Behavioral: AI City Hall Project (AIhealth4u - Public Health Central)Behavioral: AI City Hall Project (QAIAx Microcity A - AI Public Health Central)

Interventions

QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a). AI Public Health Central Microcity will focus on behavioral and psychiatric health for patients with various common mental health and addiction disorders, placed in monitored ecosystems with AI/AGI tools managing public administration resources under statistical surveys to determine to determine which fiscal viability, effectiveness and accuracy AI/AGI Health tools for mental health treatment (e.g., AI robotics; 'Quasi-Mind Ware' and Mental Health/Psychiatric Cyber-Medicine treatment applying AI Symbiosis, e.g., See 'Traum-to-Real' installation of generative AI memory into the human mind via attitude inoculation)

AI Public Health Central (Group 1)AI Public Health Central (Group 10)AI Public Health Central (Group 11)AI Public Health Central (Group 2)AI Public Health Central (Group 3)AI Public Health Central (Group 4)AI Public Health Central (Group 5)AI Public Health Central (Group 6)AI Public Health Central (Group 7)AI Public Health Central (Group 8)AI Public Health Central (Group 9)

QAIAx (AIhealth4U) - AI Public Health Central: Microcity-A (re Quantum AI Agency Aka AI City Hall Project, UPSTO App Nos. 64/074,526, 64/063,557, 63/903,181, 63/729,428: A quantum AI public health agency that provides free public health services to registered and sponsored visitors/occupants for RDT\&E under 28 U.S. Code 1498 (classified as a PPA under 10 U.S. Code 129a)

AI Public Health Central (Group 1)AI Public Health Central (Group 10)AI Public Health Central (Group 11)AI Public Health Central (Group 2)AI Public Health Central (Group 3)AI Public Health Central (Group 4)AI Public Health Central (Group 5)AI Public Health Central (Group 6)AI Public Health Central (Group 7)AI Public Health Central (Group 8)AI Public Health Central (Group 9)

Eligibility Criteria

Age17 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 17 to 99 years old.
  • Referral by a licensed health services professional (e.g., R.N., N.P., Ph.D., M.D.).
  • Referral by a non-profit organization (e.g., 501c3, university, church).
  • Referral by a public agency (e.g., case manager, social worker, parole/probation/PTS officer, judge).

You may not qualify if:

  • \* Individuals under 17 or over 99 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Administrative Office

Richmond, Virginia, 23219, United States

Location

Related Links

MeSH Terms

Conditions

Asperger SyndromeAutistic DisorderAttention Deficit Disorder with HyperactivityAlcoholismGamblingSexual BehaviorSexual Dysfunction, PhysiologicalGender DysphoriaNarcotic-Related DisordersMental DisordersMarijuana AbuseSmokingBehavior, AddictiveSexual AbstinenceOpioid-Related DisordersCocaine-Related DisordersCoitusCompulsive Sexual Behavior Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersAttention Deficit and Disruptive Behavior DisordersAlcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersRisk-TakingBehaviorDisruptive, Impulse Control, and Conduct DisordersGenital DiseasesUrogenital DiseasesSexual Dysfunctions, PsychologicalCompulsive BehaviorImpulsive BehaviorSexual and Gender Disorders

Central Study Contacts

RDTE Administrator

CONTACT

C Peterson, Administrator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2026

First Posted

June 22, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

August 3, 2026

Record last verified: 2026-07

Locations